Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Brugia malayi | Sema domain containing protein | 0.0061 | 0.2597 | 0.2597 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0027 | 0 | 0.5 |
Schistosoma mansoni | plexin | 0.0132 | 0.7975 | 1 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0061 | 0.2597 | 0.2597 |
Echinococcus multilocularis | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Echinococcus multilocularis | plexin a4 | 0.0159 | 1 | 1 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0027 | 0 | 0.5 |
Brugia malayi | Sema domain containing protein | 0.0061 | 0.2597 | 0.2597 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0034 | 0.0541 | 1 |
Echinococcus multilocularis | semaphorin 5B | 0.0061 | 0.2597 | 0.2597 |
Schistosoma mansoni | semaphorin 5-related | 0.0061 | 0.2597 | 0.3256 |
Echinococcus granulosus | semaphorin 5B | 0.0061 | 0.2597 | 0.2597 |
Schistosoma mansoni | hypothetical protein | 0.0071 | 0.3354 | 0.4205 |
Brugia malayi | Cytochrome P450 family protein | 0.0029 | 0.0182 | 0.0182 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Loa Loa (eye worm) | hypothetical protein | 0.0132 | 0.7975 | 0.7975 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0034 | 0.0541 | 1 |
Onchocerca volvulus | 0.0132 | 0.7975 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Brugia malayi | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0061 | 0.2597 | 0.3256 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0061 | 0.2597 | 0.3256 |
Brugia malayi | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Loa Loa (eye worm) | plexin A | 0.0159 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Echinococcus granulosus | plexin a4 | 0.0159 | 1 | 1 |
Brugia malayi | Plexin repeat family protein | 0.0132 | 0.7975 | 0.7975 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.3354 | 0.3354 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.2597 | 0.2597 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0029 | 0.0182 | 0.0182 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0061 | 0.2597 | 0.2597 |
Schistosoma mansoni | plexin | 0.0071 | 0.3354 | 0.4205 |
Echinococcus granulosus | semaphorin 1A | 0.0061 | 0.2597 | 0.2597 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.